(4-methylphenyl)(2-nitro-10,11-dihydrodibenzo[b,f][1,4]oxazepin-9-yl)methanone
|
|
(4-methylphenyl)(2-nitro-10,11-dihydrodibenzo[b,f][1,4]oxazepin-9-yl)methanone Eigenschaften
- Siedepunkt:
- 603.8±55.0 °C(Predicted)
- Dichte
- 1.300±0.06 g/cm3(Predicted)
- pka
- 1.03±0.20(Predicted)
Sicherheit
(4-methylphenyl)(2-nitro-10,11-dihydrodibenzo[b,f][1,4]oxazepin-9-yl)methanone Chemische Eigenschaften,Einsatz,Produktion Methoden
(4-methylphenyl)(2-nitro-10,11-dihydrodibenzo[b,f][1,4]oxazepin-9-yl)methanone Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(4-methylphenyl)(2-nitro-10,11-dihydrodibenzo[b,f][1,4]oxazepin-9-yl)methanone Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 3)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Matrix Scientific | -- |
sales@matrixscientific.com | United States | 6632 | 80 |
Key Organics Limited/Bionet Research | -- |
enquiries@keyorganics.ltd.uk | United Kingdom | 6663 | 50 |
Ryan Scientific, Inc. | -- |
ryan.reichlyn@ryansci.com | United States | 6439 | 60 |
- (4-methylphenyl)(2-nitro-10,11-dihydrodibenzo[b,f][1,4]oxazepin-9-yl)methanone
- Methanone, (10,11-dihydro-2-nitrodibenz[b,f][1,4]oxazepin-9-yl)(4-methylphenyl)-
- 866157-24-6